Home/Filings/4/0001209191-13-029941
4//SEC Filing

Hemmi Gregory 4

Accession 0001209191-13-029941

CIK 0000949699other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 8:15 PM ET

Size

12.7 KB

Accession

0001209191-13-029941

Insider Transaction Report

Form 4
Period: 2013-05-31
Hemmi Gregory
VP Chemical Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2013-05-31$0.86/sh+1,485$1,27725,721 total
  • Exercise/Conversion

    Common Stock

    2013-05-31$2.76/sh+48,515$133,90174,236 total
  • Sale

    Cmmon Stock

    2013-05-31$91.96/sh50,000$4,598,11524,236 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-05-311,485123,515 total
    Exercise: $0.86From: 2008-03-18Exp: 2018-03-18Commn Stock (1,485 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-05-3148,51523,438 total
    Exercise: $2.76From: 2007-03-13Exp: 2017-03-13Common Stock (48,515 underlying)
Footnotes (2)
  • [F1]Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). The option vests as follows: 25% of the shares subject to the option will vest on March 18, 2009 and 1/36th of the remaining shares will vest monthly thereafter. Vesting related to period ending March 18, 2009 was subject to potential acceleration upon the attainment of certain corporate events.
  • [F2]Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). The option vests in forty-eight (48) equal and successive monthly installments.

Issuer

PHARMACYCLICS INC

CIK 0000949699

Entity typeother

Related Parties

1
  • filerCIK 0001507649

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 8:15 PM ET
Size
12.7 KB